The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes
- 1 November 1995
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 286 (2), 137-146
- https://doi.org/10.1016/0014-2999(95)00436-o
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and ratsEuropean Journal of Pharmacology, 1993
- Effectiveness of piracetam in cortical myoclonusMovement Disorders, 1993
- ucb L059, a novel anti-convulsant drug: pharmacological profile in animaisEuropean Journal of Pharmacology, 1992
- Anticonvulsant and proconvulsant effects of inhibitors of GABA degradation in the amygdala-kindling modelEuropean Journal of Pharmacology, 1989
- Development of New Pharmacological Agents for Epilepsy: Lessons from the Kindling ModelEpilepsia, 1989
- Effects of Antiepileptic Drugs on GABA Responses and on Reduction of GABA Responses by PTZ and DMCM on Mouse Neurons in Cell CultureEpilepsia, 1989
- Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerationsEpilepsy Research, 1988
- Piracetam potentiates the antiepileptic action of carbamazepine in chronic experimental limbic epilepsyActa Neurologica Scandinavica, 1986
- A Model of Chronic Spontaneous Petit Mal‐like Seizures in the Rat: Comparison with Pentylenetetrazol‐Induced SeizuresEpilepsia, 1984
- Isolation of synaptic plasma membrane from brain by combined flotation-sedimentation density gradient centrifugationBiochimica et Biophysica Acta (BBA) - Biomembranes, 1974